Daré Bioscience, Inc. reported earnings results for the third quarter ended September 30, 2023. For the third quarter, the company reported revenue was USD 1 million. Net loss was USD 8.3 million compared to USD 7.02 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3059 USD | +5.77% | +9.25% | -1.00% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.00% | 30.77M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- DARE Stock
- News Daré Bioscience, Inc.
- Daré Bioscience, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2023